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Abstract.  Fibronectin (FN) is a  multidomain extracel- 
lular matrix protein that induces attachment and che- 
motactic migration of fibroblastic cells. In this study 
we analyzed the molecular determinants involved in 
the FN-induced chemotactic migration of normal and 
SV40-transformed 3T3 cells. Two different monoclonal 
antibodies to the cell-binding site of FN blocked che- 
motaxis to a  140-kD FN fragment (Ca  140) containing 
the cell-binding domain. A  monoclonal antibody to a 
determinant distant from the cell-binding site did not 
affect chemotaxis. A  synthetic tetrapeptide,  RGDS, 
which represents the major cell-attachment sequence, 
was able to compete with FN and the Ca  140 fragment 
in chemotaxis assays, but this peptide itself had no 
significant chemotactic activity. A  larger peptide en- 
compassing this sequence, GRGDSP, was chemotactic, 
while the peptide GRGESE where a  glutamic acid res- 
idue was substituted for aspartic acid, was inactive. 
Chemotactic migration could be prevented in a  dose- 
dependent manner by a  rabbit polyclonal antiserum to 
a  140-kD cell surface FN receptor.  This antibody was 
more effective on normal than on transformed 3T3 
cells. Neither the anti-FN receptor antiserum nor a 
monoclonal antibody to the cell-binding site of FN 
blocked migration induced by another potent chemoat- 
tractant, platelet-derived growth factor. These data in- 
dicate that FN-induced chemotaxis of 3T3 and SV3T3 
cells is mediated via the RGDS cell-attachment site of 
FN and the  140-kD cell surface FN receptor.  The in- 
teraction is specific and can be altered by transfor- 
mation. 
number of studies indicate that fibronectin (FN) ~  and 
certain FN  fragments are  potent chemoattractants 
for fibroblastic cells (5,  17, 27, 34, 41, 44, 47). Pre- 
sumably this activity is important in wound healing where 
fibroblasts from the surrounding tissues are recruited to the 
site of damage to produce the matrix molecules necessary for 
full repair (48).  The rate of repair is believed to be related 
to the numbers of cells recruited to the wound site and there- 
by to the level of chemoattractants and the duration of their 
production.  Chemotaxis to  FN  may also  be  involved  in 
pathological  situations  including  fibrosis  and  tumor  cell 
metastasis (2, 22, 28, 30, 31, 44, 52-54).  The chemotactic 
region of FN has been localized within a large cell-binding 
chymotryptic 160-kD peptide (47) and in a cathepsin D-de- 
rived 140-kD peptide which lacks gelatin-binding activity (3, 
5, 41). 
1.  Abbreviations  used  in  this paper:  FN,  fibronectin;  PDGE  platelet- 
derived growth factor. 
Studies with various chemoattractants in eukaryotic and 
prokaryotic cells show that the responding cells have recep- 
tors  which bind the attractant and elicit the  intracellular 
events that direct cell movement (6, 12, 22, 24, 36, 56). Here 
we have attempted to determine if the chemotactic response 
of 3T3 cells and their SV40-transformed counterpart to FN 
occurs through the RGD-attachment site of the molecule (37, 
40)  and an FN receptor (Mr  140,000) (18, 19, 51). Studies 
with antibodies to the cell-binding site in FN, with antibodies 
to the FN receptor, and with various synthetic peptides suggest 
that the cell-attachment site of FN also elicits chemotaxis. 
Materials and Methods 
Cellular Material 
313 cells and SV3T3 were kindly provided by Dr. P. Prehm (Max-Planck- 
Institfit fiir Biochemie, Munich, FRG). Cells were cultivated in DME, sup- 
plemented with 10% FBS, penicillin (100 U/ml), streptomycin (50 I.tg/ml), 
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trypsin, 0.02 % EDTA in PBS, pH 7.4). 
Chemoattractants 
FN (Sigma, Munich, FRG) was diluted with DME to 30 I.tg/ml.  Ca  140, 
a  large cathepsin D  fragment, was prepared from purified human plasma 
FN  by  mild digestion (45).  The preparation,  purification,  and  electro- 
phoretic purity of the Ca 140 fragment has been previously described (16, 
45). Ca 140 was shown previously to be a potent chemoattractant (3, 5) and 
was used here at 20 p.g/rnl. Platelet-derived growth factor (PDGF) was pur- 
chased from Collaborative Research, Inc. (Lexington, MA) and used as a 
chemoattractant at 5  ng/ml (46).  The tetrapeptide RGDS was purchased 
from Nova Biochemical AG (L~iwfelfingen,  Switzerland). The hexapeptides 
GRGDSP and GRGESP  were synthesized by Prof.  P.  Neri of Centro di 
Ricerca Interdipartimentale fer le  Scienze Mediche Avantate (CRISMA, 
University of Siena, Siena, Italy), using an automated peptide synthesizer 
(model No.  430A;  Applied Biosystems, Inc.,  Foster City, CA) equipped 
with the chemistry provided by the manufacturer. After cleavage from the 
resin with hydrogen fluoride the peptides were purified by two cycles of 
chromatography on Sephadex G10 in water, lyophilized, and stored at -20 C. 
Antibodies 
A317 and A286 are two distinct monoclonal antibodies reacting with deter- 
minants within the COOH-terminus of peptide Ca 140 (16, 45). These anti- 
bodies were kindly provided by M. Schachner (Institiit fiir Neurobiologie, 
Heidelberg,  FRG).  The monoclonal antibody 3E3,  a  gift of M.  Piersch- 
bacher (La Jolla Cancer Research Foundation, La Jolla, CA), reacts with 
the cell-attachment domain of FN (39). Goat anti-FN serum was a gift of 
Klaus von der Mark (Max-Planck-Institut, Martinsried, FRG).  The anti- 
baby hamster kidney (BHK) serum reacting with the 140-kD  FN receptor 
on BHK cells has been previously characterized (18, 19, 51). An IgG fraction 
from this antiserum was prepared by affinity chromatography on Protein 
A-Sepharose. Immunoprecipitation oftbe cell surface receptor proteins was 
performed as previously described (51). The 135-kD component of the FN 
receptor  was  purified  from  SR/BALB/c  3T3  cell  membranes on  lec- 
tin-Sepharose column followed by hydroxyapatite chromatography (20). 
For some experiments the anti-BHK antiserum was adsorbed on a receptor 
affinity column. 
Chemotaxis Assays 
These assays were carried out in Boyden chambers as described previously 
(42).  Cells were harvested in trypsin (0.05%) and EDTA (0.01%)  in PBS 
(pH 7.4). The cells were recovered by centrifugation, resuspended in DME, 
recentrifuged, and then resuspended in DME without serum. Cells (1  x 
105) were added to the upper compartment (0.8 ml) of the Boyden chamber 
and the lower compartment (0.2 ml) was filled with media usually contain- 
ing a chemoattractant, in the presence or absence of different antibodies. 
Table L Inhibition of  Chemotactic Activity of  3T3 Cells 
by Antibodies to the Cell-binding Site ofFAl 
Attractant  Antibody  Concentration  Maximal activity 
Iz  g /ml  % 
FN  -  0  100  +  22 
Ca  140  -  0  89  +  18 
Ca  140  A317  20  69  +  16 
Ca  140  A317  40  38  +  3 
Ca  140  A286  20  84  +  5 
Ca  140  A286  40  91  +  6 
Ca  140  3E3  20  38  +  14 
PDGF  -  0  I00  +  8 
PDGF  3E3  20  100  5-  15 
We analyzed the effect of different monoclonal antibodies recognizing Ca 140 
(which contains the cell-binding domain) on the migration of 3T3 cells to Ca 
140 itself (20 p.g/ml) and to PDGF (5 ng/ml). A317 and 3E3 are antibodies 
directed to the cell-binding site in Ca  140,  while A286 recognizes a deter- 
minant in a more NH2-terminal  region of the fragment. Data are expressed as 
percent of maximal migration as compared to the chemoattractant alone. Ex- 
periments were run in triplicate  and repeated twice. SDs are indicated. 
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Figure 1. Inhibition  of 3T3 and SV3T3 cell chemotaxis towards FN 
by anti-FN polyclonal  antiserum.  30 ~tg/ml of FN was placed  in 
the  lower  compartment  of  Boyden  chambers  with  increasing 
amounts  of goat anti-FN  antiserum.  3"13 and  SV3T3 cells  were 
placed in the upper compartment and the assays run for 5 h. Data 
are expressed  as migrated  cells/field.  Two separate  experiments 
were carried out with each assay performed in triplicate and did not 
differ by more than  10%. 
FN (30 Ixg/ml),  Ca 140 (20 ~tg/ml), and PDGF (5 ng/ml) were used at the 
concentrations  exerting  maximal  chemotactic  activity  (5,  34,  46)  as 
confirmed in preliminary experiments. The two compartments were sepa- 
rated by a polycarbonate flter (8 Ilm pore size; Nuclepore, Concorezzo, 
Italy)  coated  with gelatin (5  ~tg/ml;  Sigma) an attachment substrate for 
fibroblasts (42). Of the chemoattractants used, only FN has been reported 
to bind to gelatin, and Ca 140 lacks the gelatin-binding  domain (45). In some 
experiments FN and FN peptides were placed either in the upper, in the 
lower,  or in both compartments of the Boyden chamber, and the migratory 
activities were compared with those obtained when only the lower compart- 
ment contained chemoattractant (57). Cells were allowed to migrate for 5 h 
at 37~  in a  humidified atmosphere containing 5%  CO2  (3).  After this 
time, cells on the upper side of the filter were removed mechanically; the 
cells on the lower surface of the filter were fixed in ethanol, stained with 
toluidine blue, and 5 U fields per filter were counted at 160x with a micro- 
scope (Zeiss, Oberkochen, FRG). Filters were numbered at the onset of the 
assay and counted without knowledge of their identity. The fields to be 
counted were selected randomly from the surface of the migrated cells. One 
field represents ,'~1/160 of the total area of migrated cells. Each assay was 
carried out in triplicate and repeated at least twice. 
Results 
Inhibition of  Fibroblast Migration by Antibodies 
to the Cell-binding Site of  FN 
It is  well  known that  FN  is  a  potent  chemoattractant  for 
fibroblastic cells and that the active region lies within a large 
fragment (Ca 140) which contains the major cell-binding do- 
main of the molecule (38, 41, 47). The effect of three mono- 
clonal antibodies which react with this fragment were tested 
(Table I).  Monoclonals A317 and 3E3 react with the cell- 
binding site within Ca 140 while A286 recognizes a  deter- 
minant  in  a  more  NH2-terminal  region  of Ca  140  (16). 
Monoclonal antibodies  A317 and  3E3  (Table  I) as well as 
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of  3T3 and SV3T3 Cells towards FN 
Attractant  Migrated cells 
Lower compartment  Upper compartment  3T3  SV3T3 
%  % 
--  --  7+2  7+2 
FN  -  100  +  1  100  +  4 
RGDS  -  10  +  2  7  -/-  1 
GRGESP  -  6  +  1  7  +  1 
-  FN  7+2  7+4 
-  RGDS  10  +  4  9  +  4 
FN  FN  41  +  2  49  +  6 
RGDS  RGDS  14  +  4  ND 
FN  RGDS  75  +  2  32  +  2 
FN  GRGESP  102  +  7  95  +  9 
For this experiment, chemoattractants were placed either in the lower or in the 
upper compartment of chemotaxis chambers. FN was used at 30 ltg/mi. RGDS 
was used at the concentration exerting maximal activity in preliminary experi- 
ments;  i.e.,  200  I.tg/ml.  GRGESP  was used at the same concentration; other 
concentrations tested were inactive as well. Data are expressed as percent of 
maximal migration as compared to the chemoattractant alone.  Experiments 
were run in triplicate and repeated three times. SDs are indicated. 
polyclonal antiserum to the FN molecule (Fig.  1) all caused 
significant inhibition of chemotaxis to Ca 140 or FN, while 
monoclonal A286 did not. These antibodies did not inhibit 
chemotaxis of 3T3 cells to the chemoattractant PDGF (46) 
(only 3E3 shown), indicating that the inhibition of migration 
was specific to FN (Table I). These studies indicate that it 
is a portion of Ca 140 associated with the cell-binding site 
that is the principal  active sequence on FN directing the 
chemotactic migration of 3T3 cells. 
Effect of  Synthetic Peptides on Cell Migration 
The sequence Arg-Gly-Asp-Ser (RGDS) has been identified 
as the major cell-binding domain of FN (37, 38,  40).  The 
possibility that synthetic peptides containing this sequence 
were chemotactic or could inhibit FN-induced migration was 
investigated. RGDS alone in the lower compartment of the 
Boyden chamber at levels up to 1,000 ~tg/ml did not stimulate 
cell migration (Table II). In contrast, GRGDSP was found 
to elicit a dose-dependent response (Fig. 2).  The response 
was biphasic with a peak of maximal activity observed be- 
tween  10  -3 and  10  -l  laM. A  related peptide with glutamic 
acid substituted for aspartic acid was not chemotactic, nor 
did it exhibit competitive activity (Table II) at concentrations 
up to 1 mg/ml. When the RGDS peptide was added in the 
lower compartment of  the Boyden chamber together with FN 
(Table II) or the Ca 140 peptide (Table III), a dose-dependent 
reduction of cell migration was observed. A  reduction of 
FN-induced cell migration was also observed when RGDS 
was added to the upper compartment (Table II). In this case 
maximal activity was achieved with 200 gg/ml. SV3T3 cells 
were more responsive to the peptides than 3T3 cells (Table 
II).  RGDS  (Table II)  stimulated  random  migration  when 
added  to both  compartments.  To see  if the  migration  to 
GRGDSP was mostly chemotactic or chemokinetic, we ran 
a checkerboard analysis (57) using concentrations of  the pep- 
tide active in stimulating migration. Table IV shows that the 
migration of cells in the presence of equimolar concentra- 
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Figure 2. Chemotactic activity of 3T3 cells to GRGDSP synthetic 
peptide. Increasing concentrations of the peptide were used in the 
lower compartment of Boyden chambers. Data are expressed as 
migrated cells/field. GRGESP was not chemotactic for any of the 
concentrations tested. 
tions of the peptide (i.e., chemokinesis [values on the di- 
agonal]) is lower than their migration when the peptide was 
present only in the lower compartment (chemotaxis), or only 
in the upper compartment. These experiments indicate that 
the RGDS cell-binding site is involved in 3T3 and SV3T3 cell 
chemotaxis to FN and in stimulated random migration. 
Inhibition of  CeU Migration by Antibodies 
to the FN Receptor 
To investigate the role of cell surface proteins in the chemo- 
tactic response to FN, we used an antiserum (anti-BHK) that 
inhibits fibroblast attachment and spreading on FN-coated 
dishes (19). This antiserum was tested here for its ability to 
precipitate the FN receptor complex (18, 19). Under reducing 
conditions the precipitated material  migrated as  a  diffuse 
band  at Mr  140,000  (Fig.  3).  In  the  absence of reducing 
agents, two major components are observed, with molecular 
masses  of 150 and  135  kD,  respectively (Fig.  3).  Recent 
results (Tarone, G., and E  Giancotti, unpublished results) 
indicate that the two polypeptides are parts of a  heterodi- 
meric complex. When the anti-BHK antiserum was added 
to the lower compartment of  the Boyden chamber, cell migra- 
tion toward FN was inhibited in a dose-dependent manner 
(Fig. 4). The antibodies did not affect migration of cells to- 
wards  PDGE  a  potent chemoattractant (46)  known to act 
Table III. Effect of  the RGDS Peptide on the Migration 
of  3T3 Cells towards Ca 140 
Attractant  RGDS concentration  Migration 
#g/ml  % 
--  0  5+1 
Ca  140  0  100  +  20 
Ca  140  20  81  +  3 
Ca  140  200  52  +  5 
Ca  140  1,000  19  +  3 
Ca 140 was used at concentrations of 20 I.tg/ml.  Increasing concentrations of 
RGDS were used along with the chemotactic fragment in the lower compart- 
ment of Boyden chambers.  Data are expressed as percent migration as com- 
pared to Ca 140.  Experiments were run in triplicate and repeated twice. SDs 
are indicated. 
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inducing Activity for 3T3 Cells 
Upper compartment 
Lower compartment  0  10  -2 laM  10  -t  I.tM 
0  3+2  9+1  2+1 
10  -2  p.M  16  ___  2  3  +  1  2  +  1 
10  -I  p.M  10  +  2  2  -I-  1  1  +0 
Concentrations of GRGDSP active in chemotactic stimulation (Fig. 2) were put 
in the lower and/or upper compartment. The first column on the left represents 
chemotaxis, the diagonal represents chemokinetic activity. 
through a different receptor (8, 24). Furthermore, adsorption 
of the antiserum with partially purified FN receptor resulted 
in the virtually complete loss of inhibitory activity on cell 
migration (data not shown).  The possibility that antibodies 
inhibited migration by preventing adhesion of the cells to the 
upper surface of the filter was ruled out since a concentration 
of 250  I.tg/ml of antibodies in the lower compartment sig- 
nificantly inhibited migration (50%) without affecting adhe- 
sion (data not shown). The antibodies were found to be more 
Figure 3. Immunoprecipitation of the cell surface FN receptor com- 
plex. Cell surface proteins were immunoprecipitated by incubating 
[35S]methionine-labeled transformed  mouse  fibroblasts  with  the 
anti-BHK serum.  Immunocomplexes  were  recovered by Protein 
A-Sepharose  and radioactive proteins were detected by fluorogra- 
phy after electrophoretic separation in a 5-10% polyacrylamide gel 
in the presence of SDS. Two major bands with apparent molecular 
masses of 150 and  135 kD were detected in the nonreduced (NR) 
sample. These components migrate as a single diffuse band after 
reduction (R) of disulfide bonds with mercaptoethanol.  Numbers 
on the right indicate the relative mobility of molecular mass markers. 
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Figure 4. Inhibition of chemotaxis of 3T3 and SV3T3 cells to FN 
by anti-FN receptor antibodies. 30 p.g/ml FN was put in the lower 
compartment of chemotaxis chambers with increasing amounts of 
anti-BHK antibodies. 3T3 and SV3T3 cells were used as target cells 
in the upper compartment. Migration to PDGF (5 ng/ml) under the 
same experimental  conditions  was used as control.  Data are ex- 
pressed as percent migration as compared with the chemoattractant 
alone. Three independent experiments were carried out. Each assay 
was done in triplicate and did not differ by more than  10%. 
effective in preventing FN-induced directional migration of 
normal than of SV40-transformed cells. As shown in Fig. 4, 
in fact, while 200 I~g/ml gave "~50% inhibition of migration 
of normal 3T3 cells, an approximately twofold higher con- 
centration of the antibodies was necessary to obtain the same 
degree of inhibition with SV3T3  cells. 
Discussion 
FN  is  a  potent  chemoattractant,  particularly  for  mesen- 
chymal cells, and chemotactic activity resides in a cathepsin 
D-derived  fragment  (Mr  140,000)  (3,  5,  41,  47).  When 
coated onto surfaces, this peptide also mediates cell attach- 
ment by binding to FN  receptors on cell  surfaces (5,  47). 
Current concepts suggest that chemotaxis is also a receptor- 
mediated phenomenon, which allows the cells to detect and 
migrate along a  gradient of a  chemotactic factor (2,  6,  12, 
22, 24, 36, 49, 56). Due to the coincidence of attachment and 
chemotactic activities within the Ca 140 fragment of FN, it 
seemed possible that they represent different functions medi- 
ated via the same recognition system. 
In the present work, we show that RGDS-containing FN 
sequences (37, 38, 40) and the  140-kD cell surface receptor 
(18, 19, 51) known to be involved in cell-substratum adhesion 
also mediate the migratory response of 3T3 and SV3T3 cells 
to FN and an FN fragment. 
Two monoclonal antibodies (A317 and 3E3), able to block 
cell attachment by reacting with the portion of Ca 140 close 
to the cell-attachment site (16, 39), also inhibit the chemotac- 
tic response of the cells to the Ca 140 peptide. Moreover, the 
synthetic hexapeptide GRGDSP, corresponding to the cell- 
attachment sequence in FN (37, 38, 40), was able to stimulate 
both random and chemotactic migration,  although its che- 
motactic activity  is  lower (i.e.,  30%)  than  that of FN.  A 
shorter peptide, RGDS, was not significantly chemotactic it- 
self, but did reduce chemotaxis to the Ca  140 cell-binding 
peptide indicating that it can compete in FN-cell recogni- 
tion.  GRGDSP is also a  better substrate for adhesion than 
RGDS (37).  The loss of chemotactic activity of RGDS could 
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possibility is a more rapid diffusion of this small molecule 
with disruption of the gradient across the filter. 
FN-mediated cell adhesion appears to occur via cell recep- 
tors (1, 9,  11,  13,  15, 21,  23,  25,  35, 43,  50).  Using antibod- 
ies to the FN receptor of mouse fibroblasts (18, 19,  51),  we 
provided evidence  for the involvement of this molecule in 
the chemotactic response to FN.  These antibodies,  in fact, 
strongly inhibited cell migration through the filter.  Neither 
the antibodies to the cell-attachment site in FN nor the anti- 
body to the FN receptor altered chemotaxis to PDGF under 
the same experimental  conditions.  This  shows that the in- 
teractions  with  FN  are  specific  and  also  that  the  general 
chemotactic ability of the cells to translocate on the filter and 
migrate directionally is not impaired by the anti-FN and an- 
ti-FN receptor antibodies. It is likely that the 3T3 cells can 
locomote via independent means to PDGE 
It  is  interesting  to  note  that  neither  the  anti-FN,  the 
anti-FN receptor antibodies, nor the peptide completely in- 
hibited the chemotactic response to FN.  This suggests  the 
involvement of other sites  in  FN  which  are active  in  the 
chemotactic stimulation of fibroblastic cells.  The existence 
of adhesion-mediating sites on FN, different than the RGDS 
site,  have been described  (26,  31).  Our Ca  140  peptide  is 
localized 65-75 kD from the COOH-terminal end of the mol- 
ecule.  Therefore it contains the domains III and IV which 
have been investigated for adhesion and motility-promoting 
activities by McCarthy et al. (32), who suggest that an adhe- 
sion and motility-promoting site,  in addition to RGDS  (lo- 
cated in domain IV),  are present in domain III. 
Our results also indicate that both anti-FN and anti-FN 
receptor antibodies were less effective in preventing migra- 
tion of SV3T3 cells than that of 3T3 cells.  This is consistent 
with  the  fact  that  SV40-transformed  cells  display  an  en- 
hanced  chemotactic  response  to  FN  (3,  33).  In contrast, 
SV3T3  were more sensitive than 3T3  cells to the inhibitory 
effect of the RGDS peptide.  We conclude that, although the 
migration of 3T3  and SV40-transformed 3T3  cells involves 
the  same  molecular  mechanisms,  the  response  to  FN,  to 
anti-FN  receptor antibody,  and to an FN peptide is some- 
what  altered  in  SV40-transformed  cells.  Perhaps  this  is 
related  to  the  differences  in  distribution  of FN  receptor, 
which in normal cells are clustered in the adhesion plaques 
and in transformed fibroblasts have a diffuse distribution (18, 
55). It is possible that the lack of clustering of FN receptors 
within localized membrane domains may contribute to the 
higher motility of transformed cells. 
Preliminary observations that either antibodies to the FN 
receptor or synthetic peptides inhibit translocation on a ma- 
trix substrate were recently presented (4,  7,  10,  14,  29).  It 
is not surprising that antibodies or peptides able to interfere 
with cell adhesion also prevent migration on a matrix sub- 
strate. Our work presents evidence that the cell-binding do- 
main of FN and its receptor are involved in the chemotactic 
response of fibroblasts to a  gradient of FN in solution. 
In summary, our data show that the chemotaxis of 3T3 and 
SV3T3 cells is mediated through the RGDS cell attachment 
site of FN and through the FN cell surface receptor. The in- 
teraction is specific and there is preliminary evidence for its 
alteration with transformation. 
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